4//SEC Filing
Kewalramani Reshma 4
Accession 0000875320-25-000067
CIK 0000875320other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:13 PM ET
Size
4.7 KB
Accession
0000875320-25-000067
Insider Transaction Report
Form 4
Kewalramani Reshma
DirectorCEO & President
Transactions
- Award
Common Stock
2025-02-12+19,015→ 135,933 total
Footnotes (1)
- [F1]Restricted stock unit award that vests in installments beginning on 02/24/2026.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001735944
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:13 PM ET
- Size
- 4.7 KB